Form 4: NeuroPace Inc. Executive Martha Morrell Reports Stock Transaction
SEC Form 4 Filing
Martha Morrell, Chief Medical Officer of NeuroPace Inc., reports the disposition of 237 shares of common stock to cover tax obligations.
Summary
- On April 22, 2025, Martha Morrell, the Chief Medical Officer of NeuroPace Inc. (NPCE), disposed of 237 shares of common stock.
- The transaction was executed at a price of $10.94 per share.
- Following the transaction, Morrell directly owns 90,689 shares of NeuroPace Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track the buying and selling activities of individuals with privileged information.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of stock transaction |
| 04/23/2025 | Date of signature on the report |
Keywords
Form 4, NeuroPace Inc, NPCE, Martha Morrell, Chief Medical Officer, Stock Transaction, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.